| 品牌 | 貨號 | 產品規格 | 價格(RMB) | 庫存（上海） | 北京 | 武漢 | 南京 | 購買數量 |
|---|---|---|---|---|---|---|---|---|
| 源葉(MedMol) | S20672-5mg | 98% | ￥1000.00元 | 4 | - | - | - |
|
| 源葉(MedMol) | S20672-10mg | 98% | ￥1800.00元 | 5 | - | - | - |
|
| 源葉(MedMol) | S20672-25mg | 98% | ￥3600.00元 | 5 | - | - | - |
|
| 源葉(MedMol) | S20672-100mg | 98% | ￥9000.00元 | 預計交期：2-3天 | - | - | - |
|
Ropsacitinib (PF-06826647, Tyk2-IN-8, compound 10) is a selective and orally administered inhibitor of tyrosine kinase 2 (TYK2) with IC50 of 17 nM for binding to TYK2 catalytically active JH1 domain. PF-06826647 (Tyk2-IN-8, compound 10) also inhibits JAK1 and JAK2 with IC50 of 383 nM and 74 nM, respectively. PF-06826647 (Tyk2-IN-8, compound 10) is used in the treatment of psoriasis (PSO).
| 產品描述： | Ropsacitinib (PF-06826647, Tyk2-IN-8, compound 10) is a selective and orally administered inhibitor of tyrosine kinase 2 (TYK2) with IC50 of 17 nM for binding to TYK2 catalytically active JH1 domain. PF-06826647 (Tyk2-IN-8, compound 10) also inhibits JAK1 and JAK2 with IC50 of 383 nM and 74 nM, respectively. PF-06826647 (Tyk2-IN-8, compound 10) is used in the treatment of psoriasis (PSO). |
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | TyrosineKinases | ||||||||||||||||||||
| 溶解性： | soluble in DMSO | ||||||||||||||||||||
| 保存條件： | -20℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網安備 31011702002021號
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京